Senior Medical Director, Kidney Disease, Early Clinical Development CVRM

AstraZeneca·
Gaithersburg - MD, US
3mo ago
Full-timeSeniorNephrology
$281K - $421K/yr(estimated)

Description

<p>T<span><span>he Senior Medical Director will be focused on </span>Kidney Disease<span> and related conditions that </span><span>impact</span><span> kidney function</span></span><b><span>. </span></b><span><span>In this role, you will have the opportunity to work at the forefront of early clinical and translational research within CVRM. In a multidisciplinary environment, you will play a key role in progressing a rich and diverse pipeline of both small and large molecules in </span><span>numerous</span><span> active clinical programs. </span></span><span> </span></p><p></p><p></p><div><p><b><span>Who </span><span>W</span><span>e </span><span>A</span><span>re</span></b><span> </span></p></div><div><p><span><span>In </span><span>the </span>Cardiovascular, Renal &amp; Metabolism (CVRM)<span> </span>Translational Medicine &amp; Clinical Development (TSCD)<span> department</span><span>, we are investigating the </span></span><span><span>underlying factors contributing to CVRM disease progression</span></span><span><span> </span></span><span><span>using advanced scientific methodologies and data-driven drug discovery. </span></span><span><span>In this context, we are </span><span>evaluating </span><span>a wide range of different drug modalities from our rich CVRM portfolio of </span><span>compounds</span><span> </span><span>across </span><span>kidney disease</span><span> </span><span>patient populations.</span></span><span> </span></p></div><div><p><span> </span></p></div><div><p><span><span>TSCD</span><span> is where science meets </span><span>clinical drug development with a focus upon </span><span>deliver</span><span>ing</span><span> innovative</span><span>, early phase</span><span> clinical studies and accelerat</span><span>ing </span><span>human target validation</span><span> while </span><span>collaborating closely with our</span><span> late phase clinical development and regulatory</span><span> colleagues who guide our pivotal phase 3 clinical studies</span><span>.</span></span><span> </span></p></div><p></p><p></p><div><p><b><span>What </span><span>Y</span><span>ou</span><span> Wi</span><span>ll </span><span>D</span><span>o</span></b><span> </span></p></div><div><p><span><span>You will </span><span>be responsible for</span><span> managing </span><span>and </span><span>lead</span><span>ing to </span><span> </span>early phase I-II global clinical trials<span> <span> </span>and related </span><span>clinical </span><span>research projects</span><span> for compounds that are targeting </span><span>kidney disease</span><span>, </span><span>as well as serving as an expert on the design, conduct, monitoring, data interpretation, and reporting of these studies.</span></span></p></div><p></p><p><span><span>Additionally, you will work on cross-functional teams </span><span>within our </span><span>TSCD</span><span> group and across the broader global<span> </span>CVRM organization that are framing our strategies and development plans for </span><span>compounds that are targeting</span><span> cardiovascular diseases </span><span>such as</span><span> </span><span>H</span><span>eart </span><span>F</span><span>ailure,</span><span> </span><span>as well as </span><span>major</span><span> metabolic disorders</span><span>, such as </span><span>Type 2 </span><span>Diabetes, Obesity, and </span></span><span><span>Metabolic Dysfunction-Associated Steatohepatitis</span></span><span><span>, given that these disorders </span><span>intersect with </span><span>chronic kidney disease and</span><span> influence disease progression.</span><span>  </span></span></p><p></p><div><div><p><b><span><span>Responsibilities include:</span> </span></b></p></div><div><ul><li><span> <span>Lead</span><span> early </span><span>Phase</span><span> I–II global </span><span>trials</span><span> in </span><span>kidney</span><span> </span><span>disease</span><span>: clinical </span><span>strategy</span><span>, </span><span>protocol</span><span> design, </span><span>study</span><span> </span><span>conduct</span><span>, </span><span>monitoring</span><span>, data interpretation, and </span><span>reporting</span><span>, </span><span>ensuring</span><span> </span><span>scientific</span><span> </span><span>integrity</span><span>, patient </span><span>safety</span><span>, and </span><span>regulatory</span><span> </span><span>compliance</span><span>.</span></span><span> </span></li><li><span><span>Provide</span><span> clinical </span><span>leadership</span><span> to </span><span>cross-</span><span>functional</span><span> teams; </span><span>integrate</span><span> </span><span>preclinical</span><span> </span><span>insights</span><span> (</span><span>target</span><span> </span><span>selection</span><span>, </span><span>pharmacology</span><span>, in </span><span>vivo</span><span>/in vitro data) </span><span>into</span><span> early clinical plans and </span><span>seamless</span><span> transitions to late </span><span>phase</span><span> </span><span>development</span><span>.</span></span><span> </span></li><li><span><span>Contribute</span><span> to </span><span>regulatory</span><span> </span><span>interactions</span><span> and </span><span>documentation</span><span> (</span><span>e.g</span><span>., </span><span>CTAs</span><span>, INDs, </span><span>safety</span><span> </span><span>updates</span><span>, </span><span>annual</span><span> </span><span>reports</span><span>).</span></span><span> </span></li><li><span><span>Advance</span><span> the </span><span>development</span><span> and </span><span>validation</span><span> of </span><span>non</span><span>clinical</span><span> and </span><span>surrogate</span><span> </span><span>endpoints</span><span> (</span><span>including</span><span> </span><span>imaging</span><span> and </span><span>biomarkers</span><span>).</span></span><span> </span></li><li><span><span>Represent</span><span> TSCD </span><span>internally</span><span> and </span><span>externally</span><span> </span><span>through</span><span> presentations, </span><span>publications</span><span>, and </span><span>scientific</span><span> forums; </span><span>engage</span><span> </span><span>with</span><span> </span><span>external</span><span> experts and translate </span><span>insights</span><span> </span><span>into</span><span> </span><span>strategy</span><span> and </span><span>study</span><span> design.</span></span><span> </span></li><li><span><span>Help</span><span> </span><span>evolve</span><span> </span><span>trial operations</span><span> and site </span><span>engagement</span><span> to </span><span>improve</span><span> speed, </span><span>quality</span><span>, and </span><span>inclusivity</span><span> in early studies.</span></span><span> </span></li><li><span><span>Collaborate</span><span> </span><span>across</span><span> CVRM on programs in </span><span>heart</span><span> </span><span>failure</span><span>, </span><span>type</span><span> 2 diabetes, </span><span>obesity</span><span>, and </span><span>metabolic</span><span> </span><span>dysfunction-associated</span><span> </span><span>steatohepatitis</span><span>, given </span><span>their</span><span> </span><span>intersection</span><span> </span><span>with</span><span> </span><span>kidney</span><span> </span><span>disease</span><span>.</span></span><span> </span></li></ul></div></div><p></p><div><p><b><span><span>Basic Qualifications:</span> </span></b></p></div><div><ul><li><span><span>MD</span></span><u><span><span>,</span></span></u><span><span> MBBS or MD/PhD </span><span>with</span><span> </span></span><span><span><span>established</span></span></span><span><span><span> </span></span></span><span><span>clinical or research <span><span><span> </span></span></span>expertise in </span></span><span><span>in </span><span>the treatment of kidney diseases</span></span><span><span>.</span></span><span> </span></li><li><span><span>Minimum of 5<span> </span>years<span> </span>of clinical research in </span><span>academia</span><span> and/or the </span><span>pharmaceutical</span><span>/</span><span>biotechnology</span><span> </span><span>industry</span><span>.</span></span><span> </span></li><li><span><span>Experience</span><span> designing, </span><span>executing</span><span>, </span><span>monitoring</span><span>, </span><span>interpreting</span><span>, and </span><span>overseeing</span><span> </span><span>safety</span><span> in early clinical and </span><span>translational</span><span> </span><span>trials preferred.</span></span><span> </span></li><li><span><span>Strong </span><span>command</span><span> of </span><span>biomarkers</span><span>, </span><span>surrogate</span><span> </span><span>endpoints</span><span>, and </span><span>biostatistics</span><span>, </span><span>supported</span><span> by a robust </span><span>publication</span><span> record.</span></span><span> </span></li><li><span><span>Well</span></span><u><span><span> </span></span></u><span><span>developed</span><span> interpersonal </span><span>skills</span><span>, </span><span>effective</span><span> teamwork</span><span>,</span><span> and the </span><span>ability</span><span> to </span><span>engage</span><span> </span><span>stakeholders</span><span> </span><span>effectively</span><span> </span><span>across</span><span> </span><span>functions</span><span>, </span><span>geographies</span><span>, and </span><span>disciplines</span><span>.</span></span><span> </span></li></ul></div><p></p><div><p><b><span>Why AstraZeneca?</span></b><span> </span></p></div><div><p><span><span>Here, we need leadership at every level – Physicians who not only have </span><span>clinical and scientific </span><span>expertise</span><span>, but also the ability to build a case, engage multiple partners, and communicate effectively with different audiences. With that kind of remit comes great responsibility</span><span>. </span><span>We </span><span>truly believe</span><span> that everyone contributes with an outstanding set of competence. Your curiosity and passion for personal development combined with support from colleagues, mentors and leaders, will ensure you maximize your skills, abilities and contribution.</span></span></p><p></p><div><p><span><span>The annual base pay for this position ranges from $280,895 – $421,342 USD. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to </span><span>participate</span><span> in our equity-based long-term incentive program. Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage </span><span>in accordance with</span><span> the terms and conditions of the applicable plans. </span><span>Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.</span> </span></p></div><div><p><span> </span></p></div><div><p><span><span>When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That&#39;s why we work, on average, a minimum of three days per week from the office. But that doesn&#39;t mean we&#39;re not flexible. We balance the expectation of being in the office while respecting individual flexibility. </span></span></p><p><span><span>Join us in our unique and bold world.</span> </span></p></div></div><p style="text-align:inherit"></p><p style="text-align:left"><b>Date Posted</b></p>25-Nov-2025<p style="text-align:inherit"></p><p style="text-align:left"><b>Closing Date</b></p><p>Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.</p>
AstraZeneca

AstraZeneca

PHARMACEUTICAL

Small Molecules, Vaccines, Biologics

LocationCAMBRIDGE, United Kingdom
Employees89,900
Open Jobs1568
OncologyCardiovascularRespiratoryImmunologyRare Diseases
View Company Profile

Pipeline

Pre-COVID-19N/A
QuestionnairesN/A
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux DiN/A
Bone Health Observational StudyN/A
RoflumilastN/A